Literature DB >> 22492514

Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical Aβ deposition.

John V Ly1, Christopher C Rowe, Victor L Villemagne, Jorge A Zavala, Henry Ma, Ramesh Sahathevan, Graeme O'Keefe, Sylvia J Gong, Rico Gunawan, Leonid Churilov, Tim Saunder, Uwe Ackerman, Henri Tochon-Danguy, Geoffrey A Donnan.   

Abstract

BACKGROUND AND
PURPOSE: Conflicting evidence exists as to whether focal cerebral ischemia contributes to cerebral amyloid deposition. We aimed to look at Aβ deposits, detected by N-methyl-2-(4'-methylaminophenyl)-6-hydroxybenzothiazole (PiB) positron emission tomography, in patients with recent ischemic stroke. Specifically, we hypothesized that patients with recent ischemic stroke have higher local and neocortical PiB positron emission tomography retention and that this may be associated with major vascular risk factors.
METHODS: Ischemic stroke patients were studied using PiB positron emission tomography within 30 days and compared to age-matched controls. Distribution volume ratio maps were created using Logan graphical analysis with the cerebellar cortex as a reference.
RESULTS: Among the 21 ischemic stroke patients (median age, 76 years; interquartile range, 68-77), the ipsilateral peri-infarct region PiB retention was higher compared to the contralateral mirror region, with a PiB distribution volume ratio difference of 0.29 (95% CI, 0.2-0.44; P=0.001) at median 10 (interquartile range, 7-14) days after stroke. Two patients also had higher PiB retention within the infarct compared to the contralateral side. There was no difference in the neocortical PiB retention elsewhere in the brain among ischemic stroke patients compared with 22 age-matched normal controls (P=0.22). Among the risk factors in the ischemic stroke patients, diabetes was associated with a higher neocortical PiB retention (Spearman Rho=0.48; 95% CI, 0.28-0.72).
CONCLUSIONS: PiB retention was higher in the peri-infarct region among patients with recent ischemic stroke. This did not translate into a higher global neocortical PiB retention except possibly in patients with diabetes. The cause of the focal PiB retention is uncertain and requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492514     DOI: 10.1161/STROKEAHA.111.636266

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

Review 1.  Amyloid-β positron emission tomography imaging probes: a critical review.

Authors:  Vladimir Kepe; Mateen C Moghbel; Bengt Långström; Habib Zaidi; Harry V Vinters; Sung-Cheng Huang; Nagichettiar Satyamurthy; Doris Doudet; Eyal Mishani; Robert M Cohen; Poul F Høilund-Carlsen; Abass Alavi; Jorge R Barrio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.

Authors:  Jens Göttler; Christine Preibisch; Isabelle Riederer; Lorenzo Pasquini; Panagiotis Alexopoulos; Karl Peter Bohn; Igor Yakushev; Ebba Beller; Stephan Kaczmarz; Claus Zimmer; Timo Grimmer; Alexander Drzezga; Christian Sorg
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-12       Impact factor: 6.200

3.  Serum Aβ is predictive for short-term neurological deficits after acute ischemic stroke.

Authors:  Yu-Hui Liu; Hong-Yuan Cao; Ye-Ran Wang; Shu-Sheng Jiao; Xian-Le Bu; Fan Zeng; Qing-Hua Wang; Jing Li; Juan Deng; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Neurotox Res       Date:  2015-01-23       Impact factor: 3.911

4.  White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.

Authors:  Young Noh; Sang Won Seo; Seun Jeon; Jong Min Lee; Jung-Hyun Kim; Geon Ha Kim; Hanna Cho; Cindy W Yoon; Hee Jin Kim; Byoung Seok Ye; Sung Tae Kim; Yearn Seong Choe; Kyung-Han Lee; Jae Seung Kim; Michael Ewers; Michael W Weiner; Jae-Hong Lee; David J Werring; Dae Ryong Kang; Chang Soo Kim; Duk L Na
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 5.  Cerebral amyloid PET imaging in Alzheimer's disease.

Authors:  Clifford R Jack; Jorge R Barrio; Vladimir Kepe
Journal:  Acta Neuropathol       Date:  2013-10-08       Impact factor: 17.088

Review 6.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

Review 7.  Is Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment?

Authors:  Fubing Ouyang; Zimu Jiang; Xinran Chen; Yicong Chen; Jiating Wei; Shihui Xing; Jian Zhang; Yuhua Fan; Jinsheng Zeng
Journal:  Transl Stroke Res       Date:  2021-06-30       Impact factor: 6.829

Review 8.  PET imaging of the neurovascular interface in cerebrovascular disease.

Authors:  Nicholas R Evans; Jason M Tarkin; John R Buscombe; Hugh S Markus; James H F Rudd; Elizabeth A Warburton
Journal:  Nat Rev Neurol       Date:  2017-10-06       Impact factor: 42.937

9.  Positron Emission Tomographic Imaging in Stroke: Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic Stroke.

Authors:  Ramesh Sahathevan; Thomas Linden; Victor L Villemagne; Leonid Churilov; John V Ly; Christopher Rowe; Geoffrey Donnan; Amy Brodtmann
Journal:  Stroke       Date:  2015-11-17       Impact factor: 7.914

Review 10.  Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET.

Authors:  Chetsadaporn Promteangtrong; Marcus Kolber; Priya Ramchandra; Mateen Moghbel; Sina Houshmand; Michael Schöll; Thomas J Werner; Abass Alavi; Carlos Buchpiguel
Journal:  Dement Neuropsychol       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.